For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
News Release
Drug Re-Importation Bill: Cheaper Drugs Today, But Fewer Medicines Tomorrow
Contact for Interviews: Richard Morrison, 202.331.2273 or Jody Clarke, 202.331.2252 Washington, D.C., July 25, 2003—The vote by the U.S. House to allow the re-importation of…
Op-Eds
Much Ado About Nothing?
The last year has been a bad one for future AIDS victims. The U.N. AIDS conference in Barcelona was an activist circus. U.S. Secretary…
News Release
Senate Vote a Setback for Public Health
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />Washington, D.C., July 24, 2003—The U.S. Senate yesterday approved a measure that would allow the Food…
Op-Eds
West Nile Virus: A Public Health Crisis?
Full article available in pdf format Public health officials can only hope that this summer doesn't see a repeat of last year's…
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…